ArticleOphthalmology and therapy2022

Innovator Versus Biosimilar Ranibizumab in Polypoidal Choroidal Vasculopathy: Real-World Evidence.

Manoj Soman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.